Development of glucose-responsive 'smart' insulin systems

Area of Science:

• Biomedical Engineering
• Endocrinology
• Materials Science

Background:

• Modern insulin therapy for diabetes mellitus is complex, with risks from blood glucose fluctuations (hyperglycemia, hypoglycemia).
• Glucose-responsive insulin (GRI) technologies aim to provide insulin activity that automatically adjusts to a patient's glycemic state.
• GRI eliminates the need for continuous patient or healthcare provider monitoring.

Purpose of the Study:

• To review the historical development of GRI technologies.
• To highlight three distinct approaches to GRI development: closed-loop systems, polymer encapsulation, and molecular insulin modification.

Main Methods:

• Review of recent advancements in GRI research.
• Illustration of newly developed algorithms for continuous glucose monitoring (CGM)-based insulin delivery.
• Description of glucose-sensitive and hypoxia-sensitive polymer matrices.
• Discussion of molecular modifications of insulin and polymer-encapsulated, stem-cell-derived pancreatic β cells.

Main Results:

• Significant progress has been made in algorithm development for closed-loop systems.
• Novel glucose-sensitive modifications of existing insulin analogs have been developed.
• New polymer matrices, including hypoxia-sensitive ones, are being explored for insulin delivery.
• Advancements include polymer-encapsulated, stem-cell-derived pancreatic β cells.

Conclusions:

• While GRI technologies are not yet perfected, recent interdisciplinary advances offer a clear path toward clinical application.
• The reviewed technologies represent a significant step forward in smart insulin development.
• Further research and development are expected to lead to successful clinical implementation of GRI.